ATAI Life Sciences NVNASDAQ:ATAI
- LAST PRICE1.7359
- TODAY'S CHANGE (%)0.0559 (3.3274%)
- Bid / Lots1.7300/ 6
- Ask / Lots1.7400/ 9
- Open / Previous Close1.7000 / 1.6800
- Day Range
- 52 Week Range
- Volume710,311
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATAI |
|---|---|---|
| 09:32 ET | 40927 | 1.715 |
| 09:33 ET | 14534 | 1.7186 |
| 09:35 ET | 20824 | 1.74 |
| 09:37 ET | 20349 | 1.75 |
| 09:39 ET | 25672 | 1.75 |
| 09:42 ET | 6439 | 1.7488 |
| 09:44 ET | 10604 | 1.72 |
| 09:46 ET | 16987 | 1.73 |
| 09:48 ET | 8129 | 1.7388 |
| 09:50 ET | 7132 | 1.735 |
| 09:51 ET | 14489 | 1.715 |
| 09:53 ET | 8355 | 1.73 |
| 09:55 ET | 5771 | 1.725 |
| 09:57 ET | 12285 | 1.715 |
| 10:00 ET | 1900 | 1.7099 |
| 10:02 ET | 6642 | 1.705 |
| 10:04 ET | 2508 | 1.7096 |
| 10:06 ET | 3817 | 1.715 |
| 10:08 ET | 486 | 1.715 |
| 10:09 ET | 18575 | 1.7285 |
| 10:11 ET | 1472 | 1.73 |
| 10:13 ET | 1123 | 1.73 |
| 10:15 ET | 9026 | 1.725 |
| 10:18 ET | 4240 | 1.73 |
| 10:20 ET | 1650 | 1.73 |
| 10:22 ET | 5800 | 1.72 |
| 10:24 ET | 14626 | 1.69 |
| 10:26 ET | 16645 | 1.69 |
| 10:27 ET | 2240 | 1.705 |
| 10:29 ET | 1438 | 1.705 |
| 10:31 ET | 6713 | 1.705 |
| 10:33 ET | 5839 | 1.701 |
| 10:36 ET | 7312 | 1.715 |
| 10:38 ET | 12845 | 1.705 |
| 10:40 ET | 1686 | 1.71 |
| 10:42 ET | 3390 | 1.7 |
| 10:44 ET | 5955 | 1.695 |
| 10:45 ET | 619 | 1.695 |
| 10:47 ET | 7225 | 1.6884 |
| 10:49 ET | 3841 | 1.685 |
| 10:51 ET | 1239 | 1.69 |
| 10:54 ET | 2217 | 1.695 |
| 10:56 ET | 3660 | 1.699 |
| 10:58 ET | 1249 | 1.7 |
| 11:00 ET | 12376 | 1.705 |
| 11:02 ET | 1234 | 1.7 |
| 11:03 ET | 1300 | 1.71 |
| 11:05 ET | 2482 | 1.71 |
| 11:07 ET | 2164 | 1.715 |
| 11:09 ET | 2164 | 1.715 |
| 11:12 ET | 3491 | 1.71 |
| 11:14 ET | 6416 | 1.7 |
| 11:16 ET | 3890 | 1.705 |
| 11:18 ET | 200 | 1.705 |
| 11:20 ET | 3076 | 1.71 |
| 11:21 ET | 4378 | 1.72 |
| 11:23 ET | 2021 | 1.7205 |
| 11:25 ET | 2660 | 1.725 |
| 11:27 ET | 1457 | 1.73 |
| 11:30 ET | 12753 | 1.72 |
| 11:32 ET | 1000 | 1.725 |
| 11:34 ET | 1900 | 1.7231 |
| 11:36 ET | 4061 | 1.725 |
| 11:38 ET | 3034 | 1.725 |
| 11:39 ET | 6501 | 1.715 |
| 11:41 ET | 1165 | 1.715 |
| 11:43 ET | 11721 | 1.715 |
| 11:45 ET | 902 | 1.71 |
| 11:48 ET | 1986 | 1.715 |
| 11:50 ET | 700 | 1.715 |
| 11:52 ET | 6820 | 1.705 |
| 11:54 ET | 2432 | 1.705 |
| 11:56 ET | 600 | 1.71 |
| 11:57 ET | 1600 | 1.715 |
| 11:59 ET | 18680 | 1.71 |
| 12:01 ET | 6303 | 1.71 |
| 12:03 ET | 841 | 1.72 |
| 12:06 ET | 7955 | 1.715 |
| 12:08 ET | 1958 | 1.715 |
| 12:10 ET | 7758 | 1.715 |
| 12:12 ET | 2083 | 1.72 |
| 12:14 ET | 2200 | 1.72 |
| 12:15 ET | 860 | 1.72 |
| 12:17 ET | 2127 | 1.715 |
| 12:19 ET | 800 | 1.715 |
| 12:21 ET | 3902 | 1.72 |
| 12:24 ET | 1227 | 1.715 |
| 12:26 ET | 2225 | 1.715 |
| 12:28 ET | 7577 | 1.715 |
| 12:30 ET | 2761 | 1.715 |
| 12:32 ET | 2296 | 1.71 |
| 12:33 ET | 3576 | 1.715 |
| 12:35 ET | 1350 | 1.7197 |
| 12:37 ET | 1097 | 1.715 |
| 12:39 ET | 907 | 1.715 |
| 12:42 ET | 1483 | 1.71 |
| 12:44 ET | 500 | 1.71 |
| 12:46 ET | 722 | 1.715 |
| 12:48 ET | 2293 | 1.7191 |
| 12:50 ET | 21548 | 1.735 |
| 12:51 ET | 2148 | 1.735 |
| 12:53 ET | 10073 | 1.745 |
| 12:55 ET | 5144 | 1.75 |
| 12:57 ET | 3253 | 1.7415 |
| 01:00 ET | 565 | 1.745 |
| 01:02 ET | 2282 | 1.7477 |
| 01:04 ET | 8574 | 1.7395 |
| 01:06 ET | 5720 | 1.745 |
| 01:08 ET | 15238 | 1.7359 |
Nov 18, 2024
DJ ATAI Life Sciences Is Maintained at Buy by HC Wainwright & Co., from 12:57PM ET on Monday Nov 18, 2024 by Dow Jones
12:57PM ET on Monday Nov 18, 2024 by Dow JonesDJ ATAI Life Sciences Is Maintained at Buy by Canaccord Genuity, from 9:27AM ET on Monday Nov 18, 2024 by Dow Jones
9:27AM ET on Monday Nov 18, 2024 by Dow Jones
Nov 13, 2024
Press Release: atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates, from 8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 13, 2024 by Dow Jonesatai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates, from 8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 11, 2024
Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer, from 7:30AM ET on Monday Nov 11, 2024 by Dow Jones
7:30AM ET on Monday Nov 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ATAI Life Sciences NV | 270.2M | -2.2x | --- |
Lyell Immunopharma Inc | 265.3M | -1.2x | --- |
Tevogen Bio Holdings Inc | 256.0M | 3.7x | --- |
aTyr Pharma Inc | 254.3M | -3.5x | --- |
Rezolute Inc | 284.5M | -3.8x | --- |
Atea Pharmaceuticals Inc | 284.6M | -1.6x | --- |
Company Information
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.
Contact Information
- Headquarters
- Wallstrasse 16Berlin, Germany 10179
- Phone
- 892-153-9035
- Fax
- ---
Executives
- Chairman of the Supervisory Board
- Christian Angermayer
- Co-Chief Executive Officer
- Florian Brand
- Co-Chief Executive Officer
- Srinivas Rao
- Chief Financial Officer
- Anne Johnson
- Chief Business Officer
- Sahil Kirpekar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $270.2M |
|---|---|
Revenue (TTM) | $331.0K |
Shares Outstanding | 167.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.04 |
EPS | $-0.80 |
Book Value | $1.46 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 816.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -32,304.53% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
